Yuichi Sumii

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
DepartmentPostDoc
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sumii Y, Fujii K, Kondo T, Urata T, Kimura M, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Otsuka F, Maeda Y, Fujii N. Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective study. Transfusion. 2023 11; 63(11):2120-2130. PMID: 37792312.
      Citations:    Fields:    Translation:HumansCells
    2. Kondo T, Fujii K, Fujii N, Sumii Y, Urata T, Kimura M, Matsuda M, Ikegawa S, Washio K, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Otsuka F, Maeda Y. Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch. Transfusion. 2023 07; 63(7):1344-1353. PMID: 37293978.
      Citations:    Fields:    Translation:HumansCells
    3. Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura MF, Sugiura H, Sando Y, Nakamura M, Meguri Y, Matsushita T, Tanimine N, Kimura M, Asada N, Ennishi D, Maeda Y, Matsuoka KI. Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023 04 24; 8(8). PMID: 37092551; PMCID: PMC10243810.
      Citations: 1     Fields:    Translation:AnimalsCells
    4. Kambara Y, Asada N, Kondo K, Sumii Y, Fujiwara Y, Seike K, Sando Y, Saeki K, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony-stimulating factor for severe hypoxemia provoked by high-dose granulocyte colony-stimulating factor administration. Transfus Med. 2022 12; 32(6):527-529. PMID: 36071619.
      Citations:    
    5. Sumii Y, Fujii N, Fujii K, Kondo T, Urata T, Kimura M, Washio K, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Otsuka F, Maeda Y. Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems. Transfusion. 2022 09; 62(9):1829-1838. PMID: 36084209.
      Citations:    
    6. Meguri Y, Asano T, Yoshioka T, Iwamoto M, Ikegawa S, Sugiura H, Kishi Y, Nakamura M, Sando Y, Kondo T, Sumii Y, Maeda Y, Matsuoka KI. Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation. Front Immunol. 2022; 13:891925. PMID: 35983059; PMCID: PMC9379320.
      Citations:    
    7. Kondo T, Fujii N, Fujii K, Sumii Y, Urata T, Kimura M, Matsuda M, Ikegawa S, Washio K, Fujiwara H, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Otsuka F, Maeda Y. Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia continuous mononuclear cell collection procedure. Transfusion. 2022 05; 62(5):1065-1072. PMID: 35322885.
      Citations:    
    8. Nakamura M, Meguri Y, Ikegawa S, Kondo T, Sumii Y, Fukumi T, Iwamoto M, Sando Y, Sugiura H, Asada N, Ennishi D, Tomida S, Fukuda-Kawaguchi E, Ishii Y, Maeda Y, Matsuoka KI. Reduced dose of PTCy followed by adjuvant a-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Sci Rep. 2021 06 23; 11(1):13125. PMID: 34162921; PMCID: PMC8222309.
      Citations:    
    9. Kondo T, Ikegawa S, Fukumi T, Sumii Y, Sugiura H, Sando Y, Nakamura M, Meguri Y, Iwamoto M, Maeda Y, Matsuoka KI. Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells. Immunohorizons. 2021 06 10; 5(6):424-437. PMID: 34112701.
      Citations:    
    10. Sugiura H, Matsuoka KI, Fukumi T, Sumii Y, Kondo T, Ikegawa S, Meguri Y, Iwamoto M, Sando Y, Nakamura M, Toji T, Ishii Y, Maeda Y. Donor Treg expansion by liposomal a-galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft-versus-host disease. Immun Inflamm Dis. 2021 09; 9(3):721-733. PMID: 33942544; PMCID: PMC8342231.
      Citations:    
    11. Abe M, Fujii N, Mizuhara K, Urata T, Sumii Y, Fujiwara Y, Seike K, Sando Y, Nakamura M, Fujii K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Maeda Y. Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report. Leuk Res Rep. 2021; 15:100241. PMID: 34007785; PMCID: PMC8111671.
      Citations:    
    12. Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2021 Mar 15; 11(1):6420. PMID: 33723351; PMCID: PMC7960729.
      Citations:    
    13. Ikegawa S, Meguri Y, Mizuhara K, Fukumi T, Kobayashi H, Sumii Y, Kondo T, Sando Y, Iwamoto M, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Fujisawa Y, Imai T, Maeda Y, Matsuoka KI. Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab. Leukemia. 2021 03; 35(3):929-931. PMID: 33597730.
      Citations:    
    14. Iwamoto M, Ikegawa S, Kondo T, Meguri Y, Nakamura M, Sando Y, Sugiura H, Sumii Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Shibakura M, Maeda Y, Matsuoka KI. Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplant. 2021 04; 56(4):956-959. PMID: 33128029.
      Citations:    
    15. Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Sci Rep. 2020 10 14; 10(1):17237. PMID: 33057055; PMCID: PMC7558012.
      Citations:    
    16. Fujiwara Y, Matsuoka KI, Iwamoto M, Sumii Y, Abe M, Mizuhara K, Urata T, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Sugita J, Kobayashi H, Oto T, Maeda Y. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient. Int J Hematol. 2020 Dec; 112(6):871-877. PMID: 32803699.
      Citations:    
    17. Sumii Y, Asada N, Sato Y, Ohshima KI, Makita M, Yoshimoto Y, Sogabe Y, Imajo K, Meguri Y, Ennishi D, Nishimori H, Fujii N, Matsuoka KI, Yoshino T, Maeda Y. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series. Int J Hematol. 2020 Dec; 112(6):780-786. PMID: 32785819.
      Citations:    
    18. Mizuhara K, Fujii N, Meguri Y, Takahashi T, Aoe M, Nakamura M, Seike K, Sando Y, Fujii K, Abe M, Sumii Y, Urata T, Fujiwara Y, Saeki K, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Maeda Y. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy. Int J Hematol. 2020 Sep; 112(3):422-426. PMID: 32342335.
      Citations:    
    19. Terao T, Yamamoto K, Ikeuchi K, Wakabayashi H, Igawa T, Inoue D, Oda W, Oyama T, Kamoi C, Sumii Y, Shiraishi Y, Yamamoto Y, Niiya D, Shiote Y, Sato Y, Yoshino T, Imajo K. [Hyper-IL-6 syndrome mimicking IgG4-related disease]. Rinsho Ketsueki. 2019; 60(5):392-397. PMID: 31168001.
      Citations:    
    20. Sumii Y, Yamamoto K, Omura Y, Oda W, Kondo E, Oyama T, Kamoi C, Shiraishi Y, Yamamoto Y, Niiya D, Shiote Y, Imajo K. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma]. Rinsho Ketsueki. 2018; 59(7):889-894. PMID: 30078799.
      Citations:    
    21. Yamamoto Y, Sumii Y, Shiraishi Y, Ikeuchi K, Yamada H, Niiya D, Shiote Y, Yamamoto K, Imajo K. Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10. Rinsho Ketsueki. 2017; 58(2):161-164. PMID: 28321095.
      Citations:    
    22. Kilunga KB, Inoue T, Okano Y, Kabututu Z, Martin SK, Lazarus M, Duszenko M, Sumii Y, Kusakari Y, Matsumura H, Kai Y, Sugiyama S, Inaka K, Inui T, Urade Y. Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J Biol Chem. 2005 Jul 15; 280(28):26371-82. PMID: 15845552.
      Citations:    
    Sumii's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (120)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _